TapImmune Inc.

TapImmune Inc.
Stock Exchange Other OTC
EPS
$1.35
Market Cap
$111.85 M
Shares Outstanding
13.62 M
Public Float
12.12 M

Profile

Address
5 West Forsyth Street
Jacksonville Florida 32202
United States
Employees -
Website http://www.tapimmune.com
Updated 09/14/2018
TapImmune, Inc. is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Jacksonville, FL.

Financials

View All
Created with Highcharts 5.0.14TapImmune Inc.Net Income. Fiscal year is January-December. All values USD Thousands.5 5325 53230 88330 88334 06634 0662 4552 45510 98210 98220132014201520162017010k20k30k40k

Glynn Wilson
Chairman
Peter L. Hoang
President, Chief Executive Officer & Director